These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11196530)

  • 21. Safety overview of new disease-modifying antirheumatic drugs.
    Cush JJ
    Rheum Dis Clin North Am; 2004 May; 30(2):237-55, v. PubMed ID: 15172038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 28. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2003 Jan; 1(5):25-32. PubMed ID: 15529103
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of rheumatoid arthritis].
    Babić-Naglić D
    Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current management of rheumatoid arthritis.
    Tambar S; Ruderman EM
    Manag Care Interface; 2007 Jul; 20(7):18-24. PubMed ID: 17849729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Chakravarty K; McDonald H; Pullar T; Taggart A; Chalmers R; Oliver S; Mooney J; Somerville M; Bosworth A; Kennedy T; ;
    Rheumatology (Oxford); 2008 Jun; 47(6):924-5. PubMed ID: 16940305
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?
    Ward MM
    Arthritis Rheum; 2001 Jun; 44(6):1467-9. PubMed ID: 11407710
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 36. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 37. Antirheumatic drugs and the risk of tuberculosis.
    Mines D; Novelli L
    Clin Infect Dis; 2007 Feb; 44(4):619-20; author reply 620-1. PubMed ID: 17243073
    [No Abstract]   [Full Text] [Related]  

  • 38. Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA?
    Hamdulay SS; Mason JC
    Heart; 2009 Sep; 95(18):1471-2. PubMed ID: 19528041
    [No Abstract]   [Full Text] [Related]  

  • 39. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key randomized trials of single agents in early rheumatoid arthritis.
    van de Putte LB
    J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.